Melanoma Clinical Trial
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Summary
The purpose of this study is to expand on the ongoing post-marketing monitoring of abatacept to include all participants with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) treated with abatacept captured in Danish Database for Biologic Therapies (DANBIO).
Eligibility Criteria
Inclusion Criteria:
Diagnosis of rheumatoid arthritis (RA) or psoriatic arthritis (PsA)
Receiving treatment with abatacept
Receiving treatment with non-targeted DMARD
Receiving treatment with targeted DMARD
Exclusion Criteria:
-Not applicable
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Princeton New Jersey, 08540, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.